The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

[HTML][HTML] Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review

U Ralapanawa, R Sivakanesan - Journal of epidemiology and global …, 2021 - Springer
Abstract Background Coronary Artery Disease (CAD) is the foremost single cause of
mortality and loss of Disability Adjusted Life Years (DALYs) globally. A large percentage of …

[HTML][HTML] Defibrillation strategies for refractory ventricular fibrillation

S Cheskes, PR Verbeek, IR Drennan… - … England Journal of …, 2022 - Mass Medical Soc
Background Despite advances in defibrillation technology, shock-refractory ventricular
fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …

Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

[HTML][HTML] Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

L Dong, D Lu, R Chen, Y Lin, H Zhu, Z Zhang, S Cai… - Cancer cell, 2022 - cell.com
We performed proteogenomic characterization of intrahepatic cholangiocarcinoma (iCCA)
using paired tumor and adjacent liver tissues from 262 patients. Integrated proteogenomic …

[HTML][HTML] Role of animal models in biomedical research: a review

P Mukherjee, S Roy, D Ghosh, SK Nandi - Laboratory Animal Research, 2022 - Springer
The animal model deals with the species other than the human, as it can imitate the disease
progression, its' diagnosis as well as a treatment similar to human. Discovery of a drug …

Racism and discrimination in COVID-19 responses

D Devakumar, G Shannon, SS Bhopal… - Lancet (London …, 2020 - ncbi.nlm.nih.gov
1 Legido-Quigley H, Mateos-García JT, Campos VR, Gea-Sánchez M, Muntaner C, McKee
M. The resilience of the Spanish health system against the COVID-19 pandemic. Lancet …

The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)

S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

[HTML][HTML] Artificial intelligence in health care: bibliometric analysis

Y Guo, Z Hao, S Zhao, J Gong, F Yang - Journal of Medical Internet …, 2020 - jmir.org
Background As a critical driving power to promote health care, the health care–related
artificial intelligence (AI) literature is growing rapidly. Objective The purpose of this analysis …

Undulating changes in human plasma proteome profiles across the lifespan

B Lehallier, D Gate, N Schaum, T Nanasi, SE Lee… - Nature medicine, 2019 - nature.com
Aging is a predominant risk factor for several chronic diseases that limit healthspan.
Mechanisms of aging are thus increasingly recognized as potential therapeutic targets …